Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Matt Labenski

Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Related publications

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination With Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer

Cancer Research

Cancer Research

English

LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer

English

Reversion and Non-Reversion Mechanisms of Resistance to PARP Inhibitor or Platinum Chemotherapy in BRCA1/2-mutant Metastatic Breast Cancer

English

KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer

Frontiers in Oncology

Cancer Research

English

ISO-66, a Novel Inhibitor of Macrophage Migration Inhibitory Factor, Shows Efficacy in Melanoma and Colon Cancer Models

International Journal of Oncology

Cancer Research

English

Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients

Investigational New Drugs

English

Mechanisms of Endocrine Resistance and Novel Therapeutic Strategies in Breast Cancer

Endocrine-Related Cancer

Cancer Research

English

A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution

Molecular Biology

English

Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/P53 Mutant Lung Cancer

Cancer Research

English